Talk Title: “Next Generation Cancer Therapeutics and Cancer Scientists”
Speaker: Jay Bradner, MD
Dr. James “Jay” Bradner is the President of the Novartis Institutes for BioMedical Research (NIBR) and sits on the Executive Committee for Novartis. Prior to Novartis, Dr. Bradner was a faculty member at Harvard Medical School and a medical oncologist at Dana-Farber Cancer Institute. He is the co-founder of five biotechnology companies and has authored more than 200 scientific publications and 30 U.S. patent applications.
Founded in 1996, Novartis is a global biomedical research company whose purpose is to reimagine treatments and medicine delivery. They use innovative science and technology to address some of society’s most challenging healthcare issues.